The Translation Manchester Seminar Series is an opportunity for researchers to connect with each of the Translation Manchester Research Network (TMRN) partners and hear how they can help support and progress translational research projects. The growing network includes organisations from across the University, Greater Manchester NHS Trusts and industry. With network members supporting projects at each phase of the translational research pathway, this is your opportunity to meet them and develop future collaborations.
On 23rd June 2021, Translation Manchester welcomed Dr Martin Main from the Medicines Discovery Catapult to discuss how they support translational research.
Medicines Discovery Catapult
"At Medicines Discovery Catapult (MDC), we want to fundamentally reshape the UK’s drug-discovery industry. It’s ambitious, and it’s entirely doable.
We’re achieving our aim through collaboration with UK drug discovery organisations. We give them access to industry-leading expertise, cutting-edge technology and superior-quality data. In doing so, we smooth these organisations’ paths to success, accelerating their progress exponentially. New drugs advance to clinical trials more rapidly. Patients get life-improving medicines earlier than they otherwise would have.
MDC’s enthusiastically holistic approach is what makes us unique within drug discovery. Some of our collaborators may only need our help with one specific aspect of their project. Many, however, will find that we can assist with almost every aspect of it – from sample-sourcing, to biomarker analysis, target engagement to statistical analysis, preclinical imaging to syndicated collaborations."
